Document is current
Any future updates will be listed below
-
Authors
Golledge, Jonathan
Fernando, Malindu E.
Armstrong, David G.
-
Funding
Funding for this research was provided by:
The Heart Foundation
The Townsville Hospital and Health Services Study, Education and Research Trust Fund
Queensland Government
National Health and Medical Research Council
Australian American Fulbright Commission
National Institute for Health Care Management Foundation (R01DK124789)
- License Information
-
More Information
Article History
Accepted: 21 July 2022
First Online: 12 August 2022
Declarations
:
: The Heart Foundation, The Townsville Hospital and Health Services Study, Education and Research Trust Fund, Medical Research Futures Fund and Queensland Government supported this work. MF was supported by a Fulbright Future postdoctoral exchange scholarship through the Australian American Fulbright Commission. JG holds a Practitioner Fellowships from the National Health and Medical Research Council (1117061) and a Senior Clinical Research Fellowship from the Queensland Government, Australia. DGA holds a NIH R01 award (NIH-NIDDK, Award #: R01DK124789).
: Jonathan Golledge has previously received funding from Bayer and Amgen to deliver lectures on peripheral artery disease. Malindu E. Fernando and David G. Armstrong have no potential conflicts of interest that might be relevant to this manuscript.
: JG conceived and lead the study and performed review of the literature and writing of the manuscript and edited the manuscript. MF led the study, performed literature review, wrote and edited the manuscript and summarised the data in Tables. DGA led the study, wrote the manuscript and edited the manuscript for publication.
: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable
: Not applicable
: Not applicable
: Not applicable
